Minai-Azary Jennifer Lynn 4
4 · Context Therapeutics Inc. · Filed Jun 10, 2025
Insider Transaction Report
Form 4
Minai-Azary Jennifer Lynn
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-06-06$0.64/sh+40,010$25,486→ 80,010 total
Footnotes (1)
- [F1]The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.57 - $0.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.